Tenet Healthcare (NYSE:THC) Price Target Raised to $270.00

Tenet Healthcare (NYSE:THC) had its target price upped by Truist Financial from $240.00 to $270.00 in a report published on Tuesday morning, Marketbeat.com reports. They currently have a buy rating on the stock.

Several other equities research analysts have also commented on the stock. TD Cowen reaffirmed a “buy” rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Cantor Fitzgerald increased their price target on shares of Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 29th. Wall Street Zen raised shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 31st. UBS Group raised their target price on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, Jefferies Financial Group boosted their price target on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $246.71.

Tenet Healthcare Price Performance

NYSE THC opened at $227.68 on Tuesday. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The company has a market capitalization of $19.80 billion, a price-to-earnings ratio of 14.70, a PEG ratio of 1.14 and a beta of 1.44. The stock has a 50-day moving average of $201.26 and a 200 day moving average of $196.69. Tenet Healthcare has a one year low of $109.82 and a one year high of $235.77.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s quarterly revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the company posted $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts forecast that Tenet Healthcare will post 12.24 EPS for the current year.

Insider Activity at Tenet Healthcare

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. This represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 0.81% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several institutional investors and hedge funds have recently modified their holdings of THC. AlphaQuest LLC raised its position in Tenet Healthcare by 230.8% during the second quarter. AlphaQuest LLC now owns 1,763 shares of the company’s stock valued at $310,000 after purchasing an additional 1,230 shares in the last quarter. WCM Investment Management LLC grew its holdings in shares of Tenet Healthcare by 244.4% in the third quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after purchasing an additional 362,083 shares during the last quarter. Winnow Wealth LLC bought a new position in shares of Tenet Healthcare during the third quarter valued at about $1,129,000. Cerity Partners LLC lifted its holdings in Tenet Healthcare by 10.4% in the 2nd quarter. Cerity Partners LLC now owns 120,623 shares of the company’s stock worth $21,230,000 after buying an additional 11,395 shares during the period. Finally, Savant Capital LLC lifted its stake in Tenet Healthcare by 27.5% in the third quarter. Savant Capital LLC now owns 16,894 shares of the company’s stock worth $3,430,000 after acquiring an additional 3,647 shares during the period. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.